February 28, 2018 / 12:27 AM / 3 months ago

BRIEF-Clinuvel Pharmaceuticals Says H1 Net Profit $1.4 Mln

Feb 28 (Reuters) - Clinuvel Pharmaceuticals Ltd:

* H1 REVENUES FROM CONTINUING ACTIVITIES ROSE 3 PERCENT TO $7.2 MILLION

* H1 NET PROFIT FOR PERIOD ATTRIBUTED TO MEMBERS DOWN 44 PERCENT TO $1.4 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below